Serum Elabela Level Significantly Increased in Patients with Complete Heart Block

Abstract Objective: To investigate the change in serum Elabela level, a new apelinergic system peptide, in patients with complete atrioventricular (AV) block and healthy controls. Methods: The study included 50 patients with planned cardiac pacemaker (PM) implantation due to complete AV block and...

Full description

Bibliographic Details
Main Authors: Armağan Acele, Atilla Bulut, Yurdaer Donmez, Mevlut Koc
Format: Article
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular 2020-06-01
Series:Brazilian Journal of Cardiovascular Surgery
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382020000500014&tlng=en
_version_ 1818252598876045312
author Armağan Acele
Atilla Bulut
Yurdaer Donmez
Mevlut Koc
author_facet Armağan Acele
Atilla Bulut
Yurdaer Donmez
Mevlut Koc
author_sort Armağan Acele
collection DOAJ
description Abstract Objective: To investigate the change in serum Elabela level, a new apelinergic system peptide, in patients with complete atrioventricular (AV) block and healthy controls. Methods: The study included 50 patients with planned cardiac pacemaker (PM) implantation due to complete AV block and 50 healthy controls with similar age and gender. Elabela level was measured in addition to routine anamnesis, physical examination, and laboratory tests. Patients were divided into two groups, with and without AV block, and then compared. Results: In patients with AV block, serum Elabela level was significantly higher and heart rate and cardiac output were significantly lower than in healthy controls. Serum Elabela level was found to be positively correlated with high-sensitive C-reactive protein and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, but negatively correlated with heart rate, high-density lipoprotein cholesterol, and cardiac output. In linear regression analysis, it was found that these parameters were only closely related to heart rate and NT-proBNP. Serum Elabela level was determined in the patients with AV block independently; an Elabela level > 9.5 ng/ml determined the risk of complete AV-block with 90.2% sensitivity and 88.0% specificity. Conclusion: In patients with complete AV block, the serum Elabela level increases significantly before the PM implantation procedure. According to the results of our study, it was concluded that serum Elabela level could be used in the early determination of patients with complete AV block.
first_indexed 2024-12-12T16:26:44Z
format Article
id doaj.art-6bf2cfb8cf694052a8abbd3d9e1d5ee5
institution Directory Open Access Journal
issn 1678-9741
language English
last_indexed 2024-12-12T16:26:44Z
publishDate 2020-06-01
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format Article
series Brazilian Journal of Cardiovascular Surgery
spelling doaj.art-6bf2cfb8cf694052a8abbd3d9e1d5ee52022-12-22T00:18:52ZengSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery1678-97412020-06-0135568368810.21470/1678-9741-2019-0461Serum Elabela Level Significantly Increased in Patients with Complete Heart BlockArmağan AceleAtilla BulutYurdaer Donmezhttps://orcid.org/0000-0003-4745-7801Mevlut KocAbstract Objective: To investigate the change in serum Elabela level, a new apelinergic system peptide, in patients with complete atrioventricular (AV) block and healthy controls. Methods: The study included 50 patients with planned cardiac pacemaker (PM) implantation due to complete AV block and 50 healthy controls with similar age and gender. Elabela level was measured in addition to routine anamnesis, physical examination, and laboratory tests. Patients were divided into two groups, with and without AV block, and then compared. Results: In patients with AV block, serum Elabela level was significantly higher and heart rate and cardiac output were significantly lower than in healthy controls. Serum Elabela level was found to be positively correlated with high-sensitive C-reactive protein and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, but negatively correlated with heart rate, high-density lipoprotein cholesterol, and cardiac output. In linear regression analysis, it was found that these parameters were only closely related to heart rate and NT-proBNP. Serum Elabela level was determined in the patients with AV block independently; an Elabela level > 9.5 ng/ml determined the risk of complete AV-block with 90.2% sensitivity and 88.0% specificity. Conclusion: In patients with complete AV block, the serum Elabela level increases significantly before the PM implantation procedure. According to the results of our study, it was concluded that serum Elabela level could be used in the early determination of patients with complete AV block.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382020000500014&tlng=enAtrioventricular BlockPacemaker ArtificialCardiac OutputC-Reactive ProteinCholesterol, HDL
spellingShingle Armağan Acele
Atilla Bulut
Yurdaer Donmez
Mevlut Koc
Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
Brazilian Journal of Cardiovascular Surgery
Atrioventricular Block
Pacemaker Artificial
Cardiac Output
C-Reactive Protein
Cholesterol, HDL
title Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
title_full Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
title_fullStr Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
title_full_unstemmed Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
title_short Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
title_sort serum elabela level significantly increased in patients with complete heart block
topic Atrioventricular Block
Pacemaker Artificial
Cardiac Output
C-Reactive Protein
Cholesterol, HDL
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382020000500014&tlng=en
work_keys_str_mv AT armaganacele serumelabelalevelsignificantlyincreasedinpatientswithcompleteheartblock
AT atillabulut serumelabelalevelsignificantlyincreasedinpatientswithcompleteheartblock
AT yurdaerdonmez serumelabelalevelsignificantlyincreasedinpatientswithcompleteheartblock
AT mevlutkoc serumelabelalevelsignificantlyincreasedinpatientswithcompleteheartblock